Concepedia

Author

A. Casamassima

Istituto Tumori Bari

Also Known As

A CASAMASSIMA, A Casamassima, A. Casamassima, ADDOLORATA CASAMASSIMA, Addolorata Casamassima

43

Publications

449

Citations

11

H-Index

20

Concepts

All Affiliations

Istituto Tumori BariIstituti di Ricovero e Cura a Carattere ScientificoUniversity of Bari Aldo MoroRadiation Oncology Institute
AC

About

A. Casamassima is an author at Istituto Tumori Bari specializing in tumor biology, health sciences, and surgical oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Health Sciences

1

1

21

2

Medicine

1

1

21

3

Immunology

1

1

21

4

Surgical Oncology

1

1

21

5

Autoimmune Disease

1

1

21

A. Casamassima

×

8

Publications

339

Citations

8

H-Index

YearCitations

C-REACTIVE PROTEIN: A BIOMARKER OF SURVIVAL IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA TREATED WITH SUBCUTANEOUS INTERLEUKIN-2 BASED IMMUNOTHERAPY

A. Casamassima, Margherita Picciariello, Michele Quaranta,

The Journal of Urology

2005

105

Alexithymia, Immunity and Cervical Intraepithelial Neoplasia: Replication

Orlando Todarello, A. Casamassima, Stella Maris Daniele,

Psychotherapy and Psychosomatics

1997

54

Alexithymia, Immunity and Cervical Intraepithelial Neoplasia: A Pilot Study

Orlando Todarello, A. Casamassima, Marco Marinaccio,

Psychotherapy and Psychosomatics

1994

43

Basal cytokines profile in metastatic renal cell carcinoma patients treated with subcutaneous IL-2-based therapy compared with that of healthy donors

Michele Guida, A. Casamassima, Giulia Monticelli,

Journal of Translational Medicine

2007

43

Assessment of Nutritional and Inflammatory Status to Determine the Prevalence of Malnutrition in Patients Undergoing Surgery for Colorectal Carcinoma

Antonella Daniele, Rosa Divella, Ines Abbate,

Anticancer Research

2017

42

Long-term Subcutaneous Recombinant Interleukin-2 as Maintenance Therapy: Biological Effects and Clinical Implications

Michele Guida, Ines Abbate, A. Casamassima,

Cancer Biotherapy

1995

21

Fibrinogen: a novel predictor of responsiveness in metastatic melanoma patients treated with bio-chemotherapy: IMI (italian melanoma inter-group) trial

Michele Guida, Alessandra Ravaioli, Vanna Chiarion‐Sileni,

Journal of Translational Medicine

2003

16

Interleukin-2, interferon-alpha and medroxyprogesterone acetate in metastatic renal cell carcinoma.

Emanuele Naglieri, Massimo Lopez, G. Lelli,

PubMed

2003

15

Page 1